Search

Search Results

• CO07 | Real word management of anticoagulant therapy in brain metastasis: moving toward a multidisciplinary approach in complex cases E. Lotti¹, C. Manneschi², S. Fancelli², F. Scolari¹, F. Crudele¹, D. Poli¹, M. Berteotti¹, D. Rossini³, S. Pillozzi², L. Antonuzzo^2,3, R. Marcucci^1,3 | ¹Disease Unit, Careggi University Hospital, Firenze; ²Oncology Unit, Careggi University Hospital, Firenze; ³Department of Experimental and Clinical Biomedical Sciences, University of Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.211

  632

  PDF: 26

• CO13 | Genetic background in hypercholesterolemic patients framing cardiovascular risk A. Kura¹, E. Sticchi², G. Barbieri¹, R. Orsi¹, S. Suraci¹, G.M. Scaturro³, E. Lotti⁴, F. Crudele⁴, M. Berteotti², A.M. Gori², R. Marcucci², B. Giusti² | ¹Department of Experimental and Clinical Medicine, Firenze; ²Department of Experimental and Clinical Medicine, Atherothrombotic Diseases Center, Careggi Hospital, Firenze; ³Meyer Children’s Hospital IRCCS, Firenze; ⁴Atherothrombotic Diseases Center, Careggi Hospital, Firenze, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.217

  733

  PDF: 34

• PO134 | FAMILIAL HYPERCHOLESTEROLEMIA 57-GENE PANEL MUTATIONAL ANALYSIS: INSIGHT INTO CARDIOVASCULAR RISK GENETIC PREDISPOSITION A. Kura¹, E. Sticchi¹, G. Barbieri¹, F. Basso¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Ada Kura

  26-10-2026

  https://doi.org/10.4081/btvb.2026.950

  41

  PDF: 26

• CO060 | LP(a) AND CARDIOVASCULAR RISK IN FAMILIAL HYPERCHOLESTEROLEMIA F. Basso¹, G. Barbieri¹, E. Sticchi¹, A. Kura¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Francesca Basso

  26-10-2026

  https://doi.org/10.4081/btvb.2026.762

  54

  PDF: 30

• CO073 | THROMBIN GENERATION PROFILE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF ORAL ANTICOAGULANT TYPE M. Di Gioia¹, M. Berteotti^1|2, G. Ciarrocca Taranta², F. Alfano^1|2, F. Crudele¹, F. Cesari¹, A.M. Gori^1|2, A. Rogolino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy; ²Dep. of Experimental and Clinical Medicine, University of Florence, Italy

  Michela Di Gioia

  26-10-2026

  https://doi.org/10.4081/btvb.2026.775

  56

  PDF: 19

• CO045 | BEYOND THE VISIBLE: LIPOPROTEIN(a) AS A SILENT DRIVER OF RETINAL VASCULAR DAMAGE L. Agrelli¹, M. Berteotti², E. Lotti², F. Crudele², D. Poli², A.M. Gori², A Rogolino², D. Prisco², R. Marcucci² | ¹Department of Internal Medicine, University of Salerno, Italy; ²Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, AOU Careggi, Firenze, Italy

  Lucia Agrelli

  26-10-2026

  https://doi.org/10.4081/btvb.2026.747

  49

  PDF: 32

• CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS J. Patrussi¹, A. Vignoli^1|2, L. Tenori^1|2, A. Sorrentino³, M. Berteotti^3|4, E. Lotti⁴, F. Crudele⁴, G. Ciarrocca Taranta³, A.A. Rogolino⁴, G. Barbieri³, A.M. Gori^3|4, R. Marcucci^3|4 | ¹Dep. of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy; ²Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; ³Dep. of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ⁴Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  Andrea Sorrentino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.780

  58

  PDF: 17